Kim Sung-Han, Kang Cheol-In, Kim Hong-Bin, Youn Sung-Soo, Oh Myoung-don, Kim Eui-Chong, Park Seon-Yang, Kim Byoung-Kook, Choe Kang-Won
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Infect Control Hosp Epidemiol. 2003 Dec;24(12):897-904. doi: 10.1086/502157.
To evaluate the outcome of attempted Hickman catheter salvage in neutropenic cancer patients with Staphylococcus aureus bacteremia who were not using antibiotic lock therapy.
Retrospective cohort study.
A university-affiliated, tertiary-care hospital with 1,500 beds for adult patients.
All neutropenic cancer patients who had a Hickman catheter and S. aureus bacteremia (32 episodes in 29 patients) between January 1998 and March 2002.
Salvage attempts were defined as cases where the Hickman catheter was not removed until we obtained the results of follow-up blood cultures performed 48 to 72 hours after starting treatment with antistaphylococcal antibiotics. Salvage was considered to be successful if the Hickman catheter was still in place 3 months later without recurrent bacteremia or death.
Catheter salvage was attempted in 24 (75%) of the 32 episodes. Of the salvage attempts, the success rate was 50% (12 of 24). Salvage attempts were successful in 14% (1 of 7) of the episodes with positive follow-up blood cultures, and in 65% (11 of 17) of those with negative follow-up blood cultures (P = .07). If the analysis is confined to cases with no external signs of catheter infection, salvage attempts were successful in 14% (1 of 7) of the episodes with positive follow-up blood cultures and in 80% (8 of 10) of those with negative follow-up blood cultures (P = .02).
In neutropenic cancer patients with S. aureus bacteremia, attempted catheter salvage without antibiotic lock therapy was successful in 50% of the cases.
评估在未使用抗生素封管疗法的中性粒细胞减少的癌症患者中,尝试挽救希克曼导管的结果。
回顾性队列研究。
一家拥有1500张成人病床的大学附属医院。
1998年1月至2002年3月间所有患有希克曼导管且发生金黄色葡萄球菌菌血症的中性粒细胞减少的癌症患者(29例患者共32次发作)。
挽救尝试定义为在开始使用抗葡萄球菌抗生素治疗48至72小时后进行后续血培养,直至获得结果时才拔除希克曼导管的病例。如果3个月后希克曼导管仍在位且无复发性菌血症或死亡,则认为挽救成功。
32次发作中有24次(75%)尝试进行导管挽救。在挽救尝试中,成功率为50%(24次中的12次)。在后续血培养阳性的发作中,挽救尝试成功率为14%(7次中的1次),在后续血培养阴性的发作中成功率为65%(17次中的11次)(P = 0.07)。如果分析仅限于无导管感染外部体征的病例,在后续血培养阳性的发作中,挽救尝试成功率为14%(7次中的1次),在后续血培养阴性的发作中成功率为80%(10次中的8次)(P = 0.02)。
在患有金黄色葡萄球菌菌血症的中性粒细胞减少的癌症患者中,未使用抗生素封管疗法而尝试进行导管挽救,50%的病例获得成功。